Commercial soft contact lenses engineered with zwitterionic silver nanoparticles for effectively treating microbial keratitis

2021 ◽  
Author(s):  
Li Ma ◽  
Kaijun Li ◽  
Jiali Xia ◽  
Chaojian Chen ◽  
Yuqi Liu ◽  
...  
Keyword(s):  
Silver Nanoparticles ◽  
Contact Lenses ◽  
Microbial Keratitis ◽  
Soft Contact ◽  
Soft Contact Lenses

Episodes of Microbial Keratitis With Therapeutic Silicone Hydrogel Bandage Soft Contact Lenses

2013 ◽  
Vol 39 (5) ◽  
pp. 324-328 ◽  
Author(s):  
Arvind Saini ◽  
Christopher J. Rapuano ◽  
Peter R. Laibson ◽  
Elisabeth J. Cohen ◽  
Kristin M. Hammersmith
Keyword(s):  
Contact Lenses ◽  
Microbial Keratitis ◽  
Soft Contact ◽  
Silicone Hydrogel ◽  
Soft Contact Lenses

Peculiarities of cultivation of the monolayer of fetal fibroblasts on the soft contact lenses, with contain the collagen

2009 ◽  
Vol 21 (5) ◽  
pp. 46-50
Author(s):  
N. Pasechnikova ◽  
◽  
G. Drozhzhina ◽  
O. Ivanova ◽  
I. Nasinnik ◽  
...  
Keyword(s):  
Contact Lenses ◽  
Soft Contact ◽  
Soft Contact Lenses ◽  
Fetal Fibroblasts

Modification of therapeutic silicone-hydrogel soft contact lenses

2016 ◽  
Vol 16 (3) ◽  
pp. 117-120 ◽  
Author(s):  
T.N. Safonova ◽  
◽  
I.A. Novikov ◽  
V.I. Boev ◽  
O.V. Gladkova ◽  
...  
Keyword(s):  
Contact Lenses ◽  
Soft Contact ◽  
Silicone Hydrogel ◽  
Soft Contact Lenses

scholarly journals Myopia Control with Combination Low-Dose Atropine and Peripheral Defocus Soft Contact Lenses: A Case Series

2021 ◽  
pp. 548-554
Author(s):  
Nir Erdinest ◽  
Naomi London ◽  
Nadav Levinger ◽  
Yair Morad
Keyword(s):  
Low Dose ◽  
Contact Lenses ◽  
Case Series ◽  
Concentric Circle ◽  
Retrospective Case ◽  
Soft Contact ◽  
Myopia Progression ◽  
Soft Contact Lenses ◽  
Center Distance ◽  
Myopia Control

The goal of this retrospective case series is to demonstrate the effectivity of combination low-dose atropine therapy with peripheral defocus, double concentric circle design with a center distance soft contact lenses at controlling myopia progression over 1 year of treatment. Included in this series are 3 female children aged 8–10 years with progressing myopia averaging −4.37 ± 0.88 D at the beginning of treatment. Their average annual myopic progression during the 3 years prior to therapy was 1.12 ± 0.75 D. They had not attempted any myopia control treatments prior to this therapy. The children were treated with a combination of 0.01% atropine therapy with spherical peripheral defocus daily replacement soft lenses MiSight<sup>®</sup> 1 day (Cooper Vision, Phoenix, AZ, USA). They underwent cycloplegic refraction, and a slit-lamp evaluation every 6 months which confirmed no adverse reactions or staining was present. Each of the 3 children exhibited an average of 0.25 ± 0.25 D of myopia progression at the end of 1 year of treatment. To the best of the authors’ knowledge, this is the first published study exhibiting that combining low-dose atropine and peripheral defocus soft contact lenses is effective at controlling children’s moderate to severe myopia progression during 1 year of therapy.

Sign in / Sign up

Export Citation Format

Share Document